OmniZare to Debut Dielectric Tomography Imaging Platform at RSNA 2025

At RSNA 2025, OmniZare will introduce a novel imaging technology that redefines point-of-care diagnostics through its Dielectric Tomography Scanner platform. The company will showcase two system configurations at Booth 8100 in the North Hall of McCormick Place: a cranial scanner designed to detect strokes and brain injuries, and a handheld scanner aimed at wellness and trauma applications.

Utilizing safe, ultra-high frequency (UHF) radio waves (300 MHz–3 GHz), the technology enables deep tissue imaging—penetrating through bone—to deliver 3D, quantitative visualizations of dielectric tissue properties. The system can generate AI-powered diagnostic results in less than 10 seconds and is designed to cost up to 100 times less than a traditional MRI.

A Safer, Faster Alternative to Conventional Imaging

Unlike imaging modalities such as CT or MRI, which rely on ionizing radiation or powerful magnets, OmniZare’s solution is entirely non-ionizing, highly portable, and built for use in emergency and mobile settings. This includes ambulances, sports sidelines, military field care, and routine clinical environments.

“For decades, clinicians have been forced to choose between speed, safety, and diagnostic depth,” said Eric Giler, co-CEO of OmniZare. “With our technology, that compromise is over. Whether in the back of an ambulance or on the sidelines of a football game, clinicians could soon be identifying stroke type or brain injury in seconds.”

Live Demonstrations at RSNA 2025

Visitors to OmniZare’s booth will see firsthand the platform’s versatility through demonstrations of:

• Cranial Scanner: For real-time identification of hemorrhagic vs. ischemic stroke, traumatic brain injury, and small tissue lesions.

• Handheld Scanner: For assessing internal bleeding, trauma injuries, liver health, and body composition, including differentiation of visceral and subcutaneous fat.

“Our system delivers diagnostic insight from a portable, radiation-free scanner that’s safe for all patients—including children and pregnant women,” added Andre Kurs, PhD, co-CEO of OmniZare. “It overcomes limitations of ultrasound and CT by imaging through bone and air-filled structures using low-power radio waves.”

Technology Built for Portability and Accessibility

The platform’s compact form factor and ability to run entirely off-grid allow for broad use across care settings. The company is preparing a wellness-focused body composition version as its first commercial product, with clinical applications expected to follow pending regulatory approvals.

Backed by experts from MIT Lincoln Laboratory, WiTricity, and MedTech startups, OmniZare’s leadership is focused on redefining imaging for faster, safer diagnostics at scale.

Demonstrations and private sessions are available by appointment at RSNA Booth 8100, where attendees can interact with the company’s founders and engineering team.